Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Apyx Medical Corp (APYX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 200,507
  • Shares Outstanding, K 34,042
  • Annual Sales, $ 16,690 K
  • Annual Income, $ 64,010 K
  • 60-Month Beta 0.24
  • Price/Sales 12.32
  • Price/Cash Flow N/A
  • Price/Book 2.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.18
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.19
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -1,700.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.88 +52.50%
on 04/23/19
6.25 -5.44%
on 05/10/19
+2.03 (+52.32%)
since 04/22/19
3-Month
3.55 +66.48%
on 04/02/19
8.40 -29.64%
on 03/18/19
-0.79 (-11.79%)
since 02/22/19
52-Week
3.55 +66.48%
on 04/02/19
8.89 -33.52%
on 01/28/19
+2.15 (+57.18%)
since 05/22/18

Most Recent Stories

More News
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 5.91 (+0.34%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the...

APYX : 5.91 (+0.34%)
BVX : 6.48 (+1.09%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of FSNN, AAPL and APYX

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies...

APYX : 5.91 (+0.34%)
AAPL : 182.78 (-2.05%)
FSNN : 0.0950 (-5.00%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 5.91 (+0.34%)
BVX : 6.48 (+1.09%)
Apyx Medical Corporation Reports First Quarter 2019 Financial Results and Updates Fiscal Year 2019 Outlook

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(TM)...

APYX : 5.91 (+0.34%)
Apyx Medical (APYX) to Report Q1 Earnings: What's in Store?

Apyx Medical (APYX) likely to gain from J-plasma technology in Q1; margins under pressure.

APYX : 5.91 (+0.34%)
ACB : 8.61 (-0.58%)
HEXO : 6.89 (-1.43%)
CAH : 46.84 (-0.13%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the...

APYX : 5.91 (+0.34%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 5.91 (+0.34%)
BVX : 6.48 (+1.09%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARA, NTNX, BA and APYX

The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies...

ARA : 6.74 (+0.30%)
APYX : 5.91 (+0.34%)
NTNX : 36.61 (-5.20%)
BA : 352.78 (-1.66%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, VNDA, WTW and APYX

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

APYX : 5.91 (+0.34%)
AMRN : 17.60 (+1.62%)
WTW : 19.07 (-2.41%)
VNDA : 15.80 (-3.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade APYX with:

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

2nd Resistance Point 6.23
1st Resistance Point 6.06
Last Price 5.91
1st Support Level 5.80
2nd Support Level 5.71

See More

52-Week High 8.89
Fibonacci 61.8% 6.85
Fibonacci 50% 6.22
Last Price 5.91
Fibonacci 38.2% 5.59
52-Week Low 3.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar